The FREEDOM Follow-On Study https://t.co/7xlSB95gB3 AND , Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease https://t.co/Ugmf5l99WD showed clearly CABG is better for DM pat
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LARGE survival advantage. Admin data but solid analytic approach. Is CABG being underused in diabetics? @djc795 @mirvatalasnag @GilbertT
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @alxbenevides: Long-Term Survival After #Surgical Revascularization vs #PCI in Pts W/#Diabetes & #Multivessel Coronary Disease reasserte…
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @rafasadaba: CABG appears to offer survival advantage over PCI in patients with diabetes and multivessel CAD 👇 https://t.co/CUhXSvLcDA
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease | JACC: Journal of the American College of Cardiology https://t.co/mfhcsc6rV8
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease | JACC: Journal of the American College of Cardiology https://t.co/peL9PUuIBi
RT @rafasadaba: CABG appears to offer survival advantage over PCI in patients with diabetes and multivessel CAD 👇 https://t.co/CUhXSvLcDA
Diseae complexity is an important factor in MVD w data from studies supporting additional use SYNTAX Score to categorise outcomes. This type of analysis w propensity matching w'out taking account of recog scoring system may not provide individual patient
RT @DrDerekConnolly: Registry data from Canada 🇨🇦 “In patients with multivessel CAD and diabetes, CABG was associated with improved long-…
Registry data from Canada 🇨🇦 “In patients with multivessel CAD and diabetes, CABG was associated with improved long-term mortality and freedom from MACCEs compared with PCI” Should all diabetics with multi vessel disease be considered for bypass? https
RT @rafasadaba: CABG appears to offer survival advantage over PCI in patients with diabetes and multivessel CAD 👇 https://t.co/CUhXSvLcDA
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @alxbenevides: Long-Term Survival After #Surgical Revascularization vs #PCI in Pts W/#Diabetes & #Multivessel Coronary Disease reasserte…
RT @alxbenevides: Long-Term Survival After #Surgical Revascularization vs #PCI in Pts W/#Diabetes & #Multivessel Coronary Disease reasserte…
RT @alxbenevides: Long-Term Survival After #Surgical Revascularization vs #PCI in Pts W/#Diabetes & #Multivessel Coronary Disease reasserte…
CABG appears to offer survival advantage over PCI in patients with diabetes and multivessel CAD 👇 https://t.co/CUhXSvLcDA
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @alxbenevides: Long-Term Survival After #Surgical Revascularization vs #PCI in Pts W/#Diabetes & #Multivessel Coronary Disease reasserte…
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
In patients with multivessel CAD and diabetes, CABG was associated with improved long-term mortality and freedom from MACCEs compared with PCI https://t.co/3Xe4rsHJ8q via @hwijeysundera et al https://t.co/OrJ3YAcZ90
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @alxbenevides: Long-Term Survival After #Surgical Revascularization vs #PCI in Pts W/#Diabetes & #Multivessel Coronary Disease reasserte…
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
Long-Term Survival After #Surgical Revascularization vs #PCI in Pts W/#Diabetes & #Multivessel Coronary Disease reasserted! @MihaiTrofenciuc @DrMarthaGulati @CardioIAN @SABOURETCardio @mmamas1973 @vass_vassiliou https://t.co/j7JEbwSktx
RT @Susumu_Manabe: カナダオンタリオ州のデータベースを使用した、糖尿病多枝病変の患者に対するカテーテル(PCI)と手術(CABG)の比較試験。対象はPCIが4,519例、CABGが9,716例。遠隔期死亡は1.39倍、主要心事故は1.99倍PCIが高い htt…
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease | JACC: Journal of the American College of Cardiology - excellent paper by our resident @derrickytam https://t.co/3XKyCxUV9e
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization, stroke or death vs. #PCI. Landmark study led by @DouglasLeeMD @PMunkCardiacCtr & Dr. Steven Fremes @Sunnybrook. @drmikefarkou
カナダオンタリオ州のデータベースを使用した、糖尿病多枝病変の患者に対するカテーテル(PCI)と手術(CABG)の比較試験。対象はPCIが4,519例、CABGが9,716例。遠隔期死亡は1.39倍、主要心事故は1.99倍PCIが高い https://t.co/oTdw0Sk2QO https://t.co/o3pxHHCCS2